The effectiveness of the gonadotropin-releasing analogues in managing adenomyosis and its related symptoms
OA: closed
CC0
Limited metadata. Only one source feed has indexed
this record so far — no abstract, full text, or open-access copy is
available through Endo Lab. The
publisher's page (linked below)
is the canonical location for the actual content. If you have institutional
access, use "Find at my library".
AI-generated summary
This paper evaluates the effectiveness of gonadotropin-releasing analogues in managing adenomyosis and its related symptoms.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
My notes (saved in your browser only)
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (49)
- A case of adenomyosis with leiomyoma that was effectively treated with relugolix and kamishoyosan add-on therapy via openalex
- Adenomyosis: a systematic review of medical treatment via openalex
- Changes in tissue inflammation, angiogenesis and apoptosis in endometriosis, adenomyosis and uterine myoma after GnRH agonist therapy via openalex
- Clinical effects of the levonorgestrel-releasing intrauterine device in patients with adenomyosis via openalex
- Effect of gonadotropin-releasing hormone agonist on the bone mineral density of patients with endometriosis via openalex
- Effects of levonorgestrel-releasing intrauterine system and T380A intrauterine copper device on dysmenorrhea and days of bleeding in women with and without adenomyosis via openalex
- Efficacy and safety of relugolix combination therapy in women with uterine fibroids and adenomyosis: subgroup analysis of LIBERTY 1 and LIBERTY 2 via openalex
- Efficacy and uterine bleeding patterns in initiating goserelin therapy during different menstrual phases in patients with adenomyosis: a prospective cohort study via openalex
- Elagolix to medically treat a uterine adenomyoma: A case report via openalex
- Endometriosis and Medical Therapy: From Progestogens to Progesterone Resistance to GnRH Antagonists: A Review via openalex
- Estrogen and progesterone receptor isoform distribution through the menstrual cycle in uteri with and without adenomyosis via openalex
- Evaluation of the efficacy and safety of dienogest in the treatment of painful symptoms in patients with adenomyosis: a randomized, double-blind, multicenter, placebo-controlled study via openalex
- Exploring the challenges for a new classification of adenomyosis via openalex
- Gonadotropin-releasing hormone agonist and add-back therapy: what do the data show? via openalex
- Gonadotropin-releasing hormone agonist with add-back treatment is as effective and tolerable as dienogest in preventing pain recurrence after laparoscopic surgery for endometriosis via openalex
- How common is adenomyosis? A prospective study of prevalence using transvaginal ultrasound in a gynaecology clinic via openalex
- Leuprolide acetate depot and hormonal add-back in endometriosis: a 12-month study. Lupron Add-Back Study Group via openalex
- Levonorgestrel-releasing intrauterine system versus a low-dose combined oral contraceptive for treatment of adenomyotic uteri: a randomized clinical trial via openalex
- Long-term pituitary downregulation before frozen embryo transfer could improve pregnancy outcomes in women with adenomyosis via openalex
- Pathogenesis of adenomyosis: an update on molecular mechanisms via openalex
- Pharmacological Treatment for Symptomatic Adenomyosis: A Systematic Review via openalex
- Safety of medical treatments for endometriosis via openalex
- Spontaneous reversibility of bone loss induced by gonadotropin-releasing hormone analog treatment via openalex
- Steroid receptors in the uterus: implications in endometriosis via openalex
- The symptomatology of adenomyosis via openalex
- Transvaginal Ultrasound for the Diagnosis of Adenomyosis: Systematic Review and Meta-Analysis via openalex
- Treatment of endometriosis-associated pain with linzagolix, an oral gonadotropin-releasing hormone-antagonist: a randomized clinical trial via openalex
- Upregulated Talin1 synergistically boosts β-estradiol-induced proliferation and pro-angiogenesis of eutopic and ectopic endometrial stromal cells in adenomyosis via openalex
- Uterine Adenomyosis Treated by Linzagolix, an Oral Gonadotropin-Releasing Hormone Receptor Antagonist: A Pilot Study with a New 'Hit Hard First and then Maintain' Regimen of Administration via openalex
- W2123738482 via openalex
- W2987085499 via openalex
- W2084543450 via openalex
- W3049609281 via openalex
- W2084467580 via openalex
- W3203416324 via openalex
- W3210890914 via openalex
- W1925466818 via openalex
- W4387640260 via openalex
- W4391025719 via openalex
- W4391357691 via openalex
- W4401754336 via openalex
- W2038354928 via openalex
- W2276856939 via openalex
- W1979936338 via openalex
- W2160247364 via openalex
- W2153635229 via openalex
- W2790094279 via openalex
- W2898392298 via openalex
- W2972019743 via openalex
Source provenance
- openalex
- last seen: 2026-10-29T06:07:36.237560+00:00
License: CC0
· commercial use OK